We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMGN
2001
DELISTED
Immunogen Inc
IMGN
$1.13M ﹤0.01%
228,415
-7,785
-3% -$42.2K
WDFC icon
2002
WD-40
WDFC
$2.98B
$1.13M ﹤0.01%
7,004
+1,892
+37% +$316K
IFS icon
2003
Intercorp Financial Services
IFS
$6.29B
$1.13M ﹤0.01%
47,974
+26,878
+127% +$623K
NTCO
2004
DELISTED
Natura &Co Holding S.A. American Depositary Shares (each representing two Common Shares)
NTCO
$1.13M ﹤0.01%
260,211
-784,014
-75% -$3.8M
MBB icon
2005
iShares MBS ETF
MBB
$39.1B
$1.12M ﹤0.01%
+12,100
New +$1.12M
IMAQW
2006
CALL
DELISTED
International Media Acquisition Corp. Warrants
IMAQW
$1.12M ﹤0.01%
110,000
-213,666
-66% -$6.56K
ON icon
2007
ON Semiconductor
ON
$30.7B
$1.12M ﹤0.01%
+17,948
New +$1.2M
SLP icon
2008
Simulations Plus
SLP
$371M
$1.11M ﹤0.01%
30,483
+5,827
+24% +$245K
BKE icon
2009
Buckle
BKE
$2.32B
$1.11M ﹤0.01%
24,502
-37,488
-60% -$1.51M
MAXR
2010
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
$1.11M ﹤0.01%
+21,384
New +$587K
VZ icon
2011
PUT
Verizon
VZ
$197B
$1.1M ﹤0.01%
+28,000
New +$1.05M
CLF icon
2012
Cleveland-Cliffs
CLF
$6.49B
$1.1M ﹤0.01%
68,173
-2,350,545
-97% -$35.4M
DHAI
2013
DELISTED
DIH Holdings US
DHAI
$1.09M ﹤0.01%
4,280
USER
2014
DELISTED
UserTesting, Inc.
USER
$1.09M ﹤0.01%
+145,704
New +$932K
OSW icon
2015
OneSpaWorld
OSW
$2.64B
$1.09M ﹤0.01%
117,140
+56,340
+93% +$533K
VMEO
2016
DELISTED
Vimeo
VMEO
$1.09M ﹤0.01%
318,425
-38,537
-11% -$149K
CHMI
2017
Cherry Hill Mortgage Investment Corp
CHMI
$82.3M
$1.09M ﹤0.01%
188,086
+170,260
+955% +$956K
ESPR
2018
DELISTED
Esperion Therapeutics
ESPR
$1.09M ﹤0.01%
175,023
-385,964
-69% -$2.76M
TIGO icon
2019
Millicom
TIGO
$15.8B
$1.09M ﹤0.01%
86,325
-224,863
-72% -$2.81M
PL.WS
2020
CALL
DELISTED
Planet Labs PBC Warrants
PL.WS
$1.09M ﹤0.01%
250,000
IAT icon
2021
iShares US Regional Banks ETF
IAT
$673M
$1.09M ﹤0.01%
22,800
+16,600
+268% +$815K
CCEP icon
2022
Coca-Cola Europacific Partners
CCEP
$49.1B
$1.08M ﹤0.01%
19,685
-35,454
-64% -$1.78M
NVEC icon
2023
NVE Corp
NVEC
$543M
$1.08M ﹤0.01%
16,696
+9,497
+132% +$580K
SGEN
2024
DELISTED
Seagen Inc. Common Stock
SGEN
$1.08M ﹤0.01%
8,406
-135,956
-94% -$17.5M
ABVEW
2025
CALL
DELISTED
Above Food Ingredients Inc Warrants
ABVEW
$1.08M ﹤0.01%
107,213

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.